findmyKOL
Clinical trialNCT00520780CompletedPhase 3Interventional

Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)

SponsorVifor PharmaEnrollment456AnaemiaChronic Heart FailureIron DeficiencyIron Deficiency Anemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Philip A Poole-Wilson, MD FRCP

    National Heart and Lung Institute. Faculty of Medicine. Imperial College London. Dovehouse Street, London SW3 6LY, UK

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

48 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Research Sites

    Buenos Aires, Argentina

Germany
  • Research Site

    Bad Nauheim, Germany

  • Research Site

    Berlin, Germany

  • Research Site

    Göttingen, Germany

  • Research Site

    Hanover, Germany

  • Research Sites

    Heidelberg, Germany

  • Research Site

    Herford, Germany

  • Research Site

    Herne, Germany

  • Research Site

    Kiel, Germany

  • Research Site

    München, Germany

Greece
  • Research Site

    Athens, Greece

  • Research Site

    Heraklion, Greece

Italy
  • Research Site

    Ascoli Piceno, Italy

  • Research Site

    Pavia, Italy

  • Research Site

    Rome, Italy

  • Research Site

    Vicenza, Italy

Norway
  • Research Site

    Stavanger, Norway

Poland
  • Research Site

    Bialystok, Poland

  • Research Site

    Krakow, Poland

  • Research Site

    Opole, Poland

  • Research Site

    Piotrkow Trybunalski, Poland

  • Research Site

    Siedlce, Poland

  • Research Site

    Torun, Poland

  • Research Sites

    Warsaw, Poland

  • Research Site

    Wałbrzych, Poland

  • Research Site

    Wroclaw, Poland

  • Research Site

    Włocławek, Poland

  • Research Site

    Zabrze, Poland

Romania
  • Research Site

    Brasov, Romania

  • Research Sites

    Bucharest, Romania

  • Reserach Site

    Craiova, Romania

  • Research Sites

    Târgu Mureş, Romania

Russia
  • Reserach Sites

    Moscow, Russia

  • Resarch Sites

    Saint Petersburg, Russia

  • Research Sites

    Veliky Novgorod, Russia

Spain
  • Research Site

    Alicante, Spain

  • Research Sites

    Barcelona, Spain

  • Research Site

    Bilbao, Spain

  • Research Site

    Madrid, Spain

  • Research Site

    Valencia, Spain

8 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2007
Primary completion
31 Jul 2009
Completion
30 Sept 2009
Last update posted
14 Oct 2021
Registered enrollment
456
Registry id
NCT00520780

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.